MedTrace Logo

Pre-Emptive Analgesia in Dental Implant Surgery

NCT03243032 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL

Last updated 2018-10-12

No results posted yet for this study

Summary

To determine the clinical effectiveness of combined use of pre-emptive analgesia and long acting anesthesia for pain suppression following dental implant surgery as measured by a validated numerical rating scale and the information related to consumption of post-operative medications.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Ibuprofen 600 mg

Ibuprofen 600mg given 30 minutes prior to beginning of surgery

DRUG

Local anesthetic Group 1

0.5% bupivacaine with 1:200,000 epinephrine as the local anesthetic for Group 1 Experimental.

DRUG

Placebo oral capsule

Placebo (Microcrystalline Cellulose NF (Avicel PH 105) - compounded at the University of Iowa College of Dentistry Pharmacy) given 30 minutes prior to beginning of surgery

DRUG

Local anesthetic Control

2% lidocaine with 1:100,000 epinephrine as the local anesthetic for Group 2 - Control

Sponsors & Collaborators

  • Satheesh Elangovan

    lead OTHER

Principal Investigators

  • Sathesh Elangovan, BDS · University of Iowa College of Dentistry

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-06
Primary Completion
2017-11-06
Completion
2017-11-06
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03243032 on ClinicalTrials.gov